December 12, 2008 |
ZMC Announces New Lutein Patent |
Zhejiang Medicine Company Limited/Xinchang Pharmaceutical Factory (ZMC) has been issued patent #7,271,298 from the USPTO for the process for isolation and purification of Xanthophyll crystals from plant oleoresin. The patent details the simultaneous process for isolation and purification of Lutein and Zeaxanthin from crude plant oleoresin. This process provides for the highest yield rate of Lutein and Zeaxanthin to date and is expected to position ZMC as a leading global supplier for these two important dietary supplement ingredients. Lutein is a naturally occurring anti-oxidant which has been clinically proven to be beneficial in the prevention of age-related macular degeneration. Stop by our booth 477 to learn more. |
IFT assumes no responsibility or legal liability for the accuracy, completeness or usefulness of content posted here. This news posting does not serve as an endorsement by IFT of any product, service, or organization. |